Humana Inc. (NYSE:HUM) Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB lowered its holdings in Humana Inc. (NYSE:HUM) by 12.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 29,027 shares of the insurance provider’s stock after selling 4,196 shares during the period. Handelsbanken Fonder AB’s holdings in Humana were worth $7,364,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Creative Financial Designs Inc. ADV grew its holdings in Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 61 shares in the last quarter. Ashton Thomas Securities LLC acquired a new stake in Humana during the 3rd quarter valued at $31,000. Your Advocates Ltd. LLP grew its holdings in Humana by 81.8% during the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after purchasing an additional 45 shares in the last quarter. Atwood & Palmer Inc. grew its holdings in Humana by 64.5% during the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock valued at $39,000 after purchasing an additional 60 shares in the last quarter. Finally, LRI Investments LLC grew its holdings in Humana by 1,021.4% during the 3rd quarter. LRI Investments LLC now owns 157 shares of the insurance provider’s stock valued at $50,000 after purchasing an additional 143 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms recently weighed in on HUM. JPMorgan Chase & Co. lowered their price target on shares of Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a report on Tuesday, February 18th. Wells Fargo & Company decreased their price objective on shares of Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a report on Monday, November 4th. Barclays raised their price objective on shares of Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. TD Cowen raised their price objective on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $283.00 price objective on shares of Humana in a report on Wednesday, February 12th. Nineteen equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $285.68.

Humana Trading Down 5.7 %

Shares of NYSE:HUM opened at $255.77 on Friday. The company has a market cap of $30.80 billion, a PE ratio of 25.71, a P/E/G ratio of 2.05 and a beta of 0.56. The company’s 50-day moving average price is $269.41 and its 200 day moving average price is $290.00. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Sell-side analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.38%. Humana’s dividend payout ratio is presently 35.58%.

Insider Buying and Selling at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.32% of the stock is owned by corporate insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.